SensUs Event 2020

SensUs 2020 will challenge talented student teams from all over the world to develop innovative biosensing systems for the measurement unbound valproate, a biological drug that is used to treat epilepsy. The Teams will present their work on August 28, in an event full of students, industry experts, patients and healthcare professionals. The SensUs Event will be a unique chance to listen to inspiring talks, explore innovations and expand your network. This year, the Event will be held totally online, so healthcare enthousiasts from all over the globe can join.

The viewing links will follow soon!

28th of August

Program SensUs Contest

Friday 28th of August 2020

The grand opening of the fifth edition of the SensUs Contest!

During the opening, the Theme, Teams and Jury will be introduced by our awesome Master of Ceremonies Annabel Romijn!


The Teams will pitch their ideas on their business model for the Translation Potential award and their technical ideas for the Creativity award. These pitches will happen in five different channels, see the table below for which Teams present in each channel.


Channel 1

Channel 2

Channel 3

Channel 4

Channel 5


Pitch creativity SenseNC

Pitch TP Helvet’Sens

Pitch creativity TruSense

Pitch TP Minerva

Pitch creativity LxUs


Pitch creativity SenseGlasgow

Pitch TP UppSense

Pitch creativity UT+

Pitch TP BiosensUM

Pitch creativity DeTectUs


Pitch creativity Sensing Barcelona

Pitch TP AUSense

Pitch creativity EpiSense

Pitch TP T.E.S.T. 2020

Pitch creativity AixSense


Pitch creativity Minerva

Pitch TP SenseNC

Pitch creativity Helvet’Sens

Pitch TP UT+

Pitch TP SenseGlasgow


Pitch creativity UppSense

Pitch TP TruSense

Pitch creativity BiosensUM

Pitch TP Sensing Barcelona

Pitch TP EpiSense


Pitch creativity T.E.S.T. 2020

Pitch TP LxUs

Pitch creativity AUSense

Pitch TP DeTectUs

Pitch TP AixSense

The viewing links will follow soon!

Key note: Innovations in Personalized Healthcare: time for quality, not quantity

This Key-Note will be presented by Alain van Gool, professor Personalized Healthcare and he heads the Translational Metabolic Laboratory at the Radboud university medical center, with a strong passion in the application of biomarkers in translational medicine and personalized healthcare. His professional background since 1991 is a mix of academia, pharmaceutical industry, applied research institutes and university medical centers. He has been leading technology-based biomarker laboratories, cross-functional expert teams, therapeutic project teams and public-private consortia, many of which were focused on the discovery, development and implementation of translational biomarkers in a variety of therapeutic areas. His technical expertise resides most strongly in molecular profiling (various Omics approaches), analytical biomarker development, and applications in translational scientific research.

It will be about the fact that we have reached a fantastic period in biomedical science. Exponential developments in molecular technologies such as next generation sequencing and mass spectrometry have enabled us to obtain increasing insights in the molecular components of human biology and their interactions. Novel personalized diagnostics and high precision therapies that modulate selected disease mechanisms are now driving the new paradigm of precision medicine. The parallel strong developments in digital biomarker platforms like wearables and apps further drive the personalized aspect of health management, even towards prevention of un-health. Collectively, we now aim to translate interdisciplinary research to knowledge, understanding and actionable decisions for people to maintain and/or improve their health. However, while embarking on the road towards precision medicine, we are rediscovering that human physiology is a highly complex system and that we need multiple viewing angles to begin to understand the complexity, identify its key nodes and define optimal personalized therapies. To innovate to the next level, we need to be fully aware of the many lessons learned thus far and use these to translate novel molecular technologies to clinical practice. Promising developments will be highlighted.


The Closing will be the final part of the SensUs Contest.

During the Closing, we will award the Teams with the best technical ideas, business model and the most votes their awards. We will also announce the runners-up. The theme of next year will be revealed in addition to the upcoming Events.


Eindhoven University of Technology

Groene Loper 3

5612 AE Eindhoven

The Netherlands